Brief: Tiziana Life Sciences Develops Investigational New Technology To Treat Covid-19 Infections
09/04/2020 08:23
April 9 (Reuters) - Tiziana Life Sciences PLC TILST.L :
* TIZIANA LIFE SCIENCES - HAS DEVELOPED INVESTIGATIONAL NEW TECHNOLOGY TO
TREAT
COVID-19 INFECTIONS
* TIZIANA LIFE SCIENCES PLC - COMPANY BELIEVES TECHNOLOGY COULD ALSO BE
APPLICABLE
FOR USE WITH OTHER FDA APPROVED MABS AND DRUGS
* TIZIANA LIFE SCIENCES PLC - COMPANY HAS SUBMITTED A PROVISIONAL PATENT
APPLICATION FOR DELIVERY TECHNOLOGY
Source text for Eikon: ID:nGNEbjwW5V
Further company coverage: TILST.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study